Sector ratings Charles River Laboratories International, Inc. Deutsche Boerse AG
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 212.45 EUR | +8.34% |
|
+9.74% | +22.26% |
| 07-20 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… |  |
| 07-13 | BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220 | MT |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 47.88B | AAA | |||||||
| 39.09B | - | B | - | - | ||||
| 36.75B | - | |||||||
| 40.55B | AAA | |||||||
| 27.96B | A | |||||||
| 16.77B | - | - | - | - | ||||
| 15.94B | BBB | |||||||
| 13.55B | AA | |||||||
| 13.81B | AAA | |||||||
| 11.23B | AA | |||||||
| 10.69B | - | BBB | - | - | ||||
| 10.07B | - | B | - | - | ||||
| 9.3B | AA | |||||||
| 9.14B | - | A | - | - | ||||
| 8.73B | - | BBB | - | - | ||||
| 8.25B | - | B | - | - | ||||
| 8.47B | A | |||||||
| 8.78B | BB | - | ||||||
| 8.74B | AAA | |||||||
| Average | 18.19B | A | |||||||
| Weighted average by Cap. | A |
Select your edition
All financial news and data tailored to specific country editions
